There are sick things happening in the pharmaceutical industry as prices are getting jacked up higher and higher with every passing year.
Those in favor of the higher pharmaceutical costs argue prices should not be regulated in order to encourage companies to continue developing innovative medicine.
AMNOG, a memorable name for a memorable change in Germany’s pharmaceutical industry. Along with the US, Germany has also experienced issues with their own big pharma including price gouging in medications.
Created in 2011, the system took control from the companies and gave hope back to consumers.
The pharmaceutical companies must show if the new drugs they create are better than those already in existence.
Through this pharmaceutical companies are not inhibited from creating new drugs, but are held accountable for making something that actually works.
The drugs are reviewed by a non profit and non government run organization, The German Medical Association.
Thus, continuing innovation in the medical field, a main argument in support of prices being raised.
However, take in to consideration that there are medications that do not need further advancement as they are up to date and remedy current problems, like epipens and blood pressure medications.
It is different when we look at medications in terms of Alzheimer’s disease because this is an ailment that is still being researched for a cure.
At the end of the day, the medication is made for the people who need it, and they should not have to decide between their next pill or their next meal.
It is different when we look at medications in terms of Alzheimer’s disease because this is an ailment that is still being researched for a cure.
How much would it cost for you to live another day?
by Becca Steele
CougarBuzz 